{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-003492","form_type":"8-K","ticker":"NEUP","cik":"0001191070","company_name":"Neuphoria Therapeutics Inc.","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.104415+00:00","generated_at":"2026-05-28T01:44:06.707353+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Neuphoria Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq letter confirming compliance with Minimum Bid Price Rule 5450(a)(1) on Jan 10, 2025.","Common stock (NEUP) closed at $1.00 or higher for 10 consecutive business days from Dec 24, 2024 to Jan 8, 2025.","Deficiency letter previously disclosed in July 2024; compliance deadline was Jan 7, 2025.","Matter is now closed; company avoids potential delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-003492","json":"https://secwatch.observer/filing/0001213900-25-003492.json","markdown":"https://secwatch.observer/filing/0001213900-25-003492.md","text":"https://secwatch.observer/filing/0001213900-25-003492.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1191070/000121390025003492/0001213900-25-003492-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1191070/000121390025003492/ea0227706-8k_neupho.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:44:06.707353+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}